SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued? (NYSE:LLY)

Are Mounjaro maker Eli Lilly (LLY) and Ozempic marketer Novo Nordisk (NVO) overvalued? Seeking Alpha analysts weigh in on the weight-loss drug stocks. Read more here.

Related Keywords

United States ,Denmark ,Danish ,American ,Terry Chrisomalis ,Stephen Ayers ,Eli Lily ,Bristol Myers Squibb ,Edmund Ingham ,Eli Lilly ,Novo Nordisk ,Yahoo ,Goldman Sachs Research ,Big Pharma ,Yahoo Finance ,Seeking Alpha ,Wall Street ,Danish Kroner ,